Literature DB >> 17652515

Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor.

Chun-Te Wu1, Saleh Altuwaijri, William A Ricke, Shu-Pin Huang, Shuyuan Yeh, Caixia Zhang, Yuanjie Niu, Meng-Ying Tsai, Chawnshang Chang.   

Abstract

Developmental studies of the prostate have established that ductal morphogenesis, epithelial cytodifferentiation, and proliferation/apoptosis are regulated by androgens acting through stromal androgen receptor (AR). Here, we found mice lacking epithelial AR within the mature prostate (pes-ARKO) developed prostate tissue that was less differentiated and hyperproliferative relative to WT littermates. Epithelial AR protein was significantly decreased in 6-week-old mice and was nearly absent by >/=24 weeks of age. Circulating levels of testosterone, external genitalia, or fertility were not altered in pes-ARKO mice. A significant (P < 0.05) increase in bromo-deoxyuridine-positive epithelia was observed in ventral and dorsal-lateral prostates of pes-ARKO mice at 24 weeks of age. Less differentiation was observed as indicated by decreased epithelial height and glandular infolding through 24 weeks of age, differentiation markers probasin, PSP-94, and Nkx3.1 were sig nificantly decreased, and epithelial sloughing and luminal cell apoptosis increased from 6 to 32 weeks of age in pes-ARKO mice. Gain of function occurred by crossing pes-ARKO to the T857A transgenic mice containing constitutively activated AR. In T857A-pes-ARKO mice prostates were of normal size, contained glandular infoldings, and maintained high secretory epithelium, and the appropriate prostatic epithelial proliferation was restored. Collectively, these results suggest that prostatic epithelial AR plays an important role in the homeostasis of the prostate gland. These data support the hypothesis that epithelial AR controls prostate growth by suppressing epithelial proliferation in the mature gland.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652515      PMCID: PMC1937526          DOI: 10.1073/pnas.0704940104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation.

Authors:  X Wu; J Wu; J Huang; W C Powell; J Zhang; R J Matusik; F O Sangiorgi; R E Maxson; H M Sucov; P Roy-Burman
Journal:  Mech Dev       Date:  2001-03       Impact factor: 1.882

2.  Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.

Authors:  Minjung J Kim; Rajula Bhatia-Gaur; Whitney A Banach-Petrosky; Nishita Desai; Yuzhuo Wang; Simon W Hayward; Gerald R Cunha; Robert D Cardiff; Michael M Shen; Cory Abate-Shen
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

3.  Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system.

Authors:  T Kurita; Y Z Wang; A A Donjacour; C Zhao; J P Lydon; B W O'Malley; J T Isaacs; R Dahiya; G R Cunha
Journal:  Cell Death Differ       Date:  2001-02       Impact factor: 15.828

4.  Steroid hormones stimulate human prostate cancer progression and metastasis.

Authors:  William A Ricke; Kenichiro Ishii; Emily A Ricke; Jeff Simko; Yuzhuo Wang; Simon W Hayward; Gerald R Cunha
Journal:  Int J Cancer       Date:  2006-05-01       Impact factor: 7.396

5.  Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues.

Authors:  Shuyuan Yeh; Meng-Yin Tsai; Qingquan Xu; Xiao-Min Mu; Henry Lardy; Ko-En Huang; Hank Lin; Shauh-Der Yeh; Saleh Altuwaijri; Xinchang Zhou; Lianping Xing; Brendan F Boyce; Mien-Chie Hung; Su Zhang; Lin Gan; Chawnshang Chang; Min-Chi Hung
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

6.  Cell differentiation lineage in the prostate.

Authors:  Y Wang; S Hayward; M Cao; K Thayer; G Cunha
Journal:  Differentiation       Date:  2001-10       Impact factor: 3.880

Review 7.  Androgen receptor involvement in the progression of prostate cancer.

Authors:  H Suzuki; T Ueda; T Ichikawa; H Ito
Journal:  Endocr Relat Cancer       Date:  2003-06       Impact factor: 5.678

8.  Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells.

Authors:  Chawnshang Chang; Yen-Ta Chen; Shauh-Der Yeh; Qingquan Xu; Ruey-Sheng Wang; Florian Guillou; Henry Lardy; Shuyuan Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-23       Impact factor: 11.205

9.  Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.

Authors:  Michael E Wright; Ming-Jer Tsai; Ruedi Aebersold
Journal:  Mol Endocrinol       Date:  2003-05-29

Review 10.  The role of androgens and the androgen receptor in prostate cancer.

Authors:  Jose D Debes; Donald J Tindall
Journal:  Cancer Lett       Date:  2002-12-10       Impact factor: 8.679

View more
  99 in total

1.  Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.

Authors:  Ajit Vikram; Gopabandhu Jena; Poduri Ramarao
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

2.  Loss of epithelial oestrogen receptor α inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models.

Authors:  Ming Chen; Chiuan-Ren Yeh; Hong-Chiang Chang; Spencer Vitkus; Xing-Qiao Wen; Neil A Bhowmick; Andrew Wolfe; Shuyuan Yeh
Journal:  J Pathol       Date:  2011-11-09       Impact factor: 7.996

3.  Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.

Authors:  Emily A Ricke; Karin Williams; Yi-Fen Lee; Suzana Couto; Yuzhuo Wang; Simon W Hayward; Gerald R Cunha; William A Ricke
Journal:  Carcinogenesis       Date:  2012-04-25       Impact factor: 4.944

4.  Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.

Authors:  Rui Yang; Yu-Xia Ma; Lin-Feng Chen; Ying Zhou; Zhan-Po Yang; Yan Zhu; Xiao-Ling Du; Jian-Dang Shi; Hong-Shun Ma; Ju Zhang
Journal:  Asian J Androl       Date:  2010-05-17       Impact factor: 3.285

Review 5.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

6.  Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism.

Authors:  Xinyu Wu; Kun Xu; Lixia Zhang; Yan Deng; Peng Lee; Ellen Shapiro; Marie Monaco; Helen P Makarenkova; Juan Li; Herbert Lepor; Irina Grishina
Journal:  Dev Biol       Date:  2011-05-20       Impact factor: 3.582

7.  Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.

Authors:  Myles C Hodgson; Long-jiang Shao; Anna Frolov; Rile Li; Leif E Peterson; Gustavo Ayala; Michael M Ittmann; Nancy L Weigel; Irina U Agoulnik
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

8.  Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals.

Authors:  Xiaohai Wang; Soo Ok Lee; Shujie Xia; Qi Jiang; Jie Luo; Lei Li; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Cancer Ther       Date:  2013-03-27       Impact factor: 6.261

Review 9.  Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.

Authors:  Qu Deng; Dean G Tang
Journal:  Endocr Relat Cancer       Date:  2015-08-18       Impact factor: 5.678

Review 10.  Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth.

Authors:  A M Traish; A Morgentaler
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.